By Peter D. Emanuel, MD
2008-11-01
Dr. Emanuel has served as Editor-in-Chief of The Hematologist from 2005 – 2008.
The Hematologist was inaugurated in January 2004 under the
energetic leadership of Dr. Andrew Schafer as the founding
editor-in-chief. It began as a quarterly publication with the Diffusion
articles as its foundation. When Dr. Schafer was elected ASH vice
president at the 2004 annual meeting, he had to relinquish his role as
founding editor. I was selected as the next editor-in-chief and took
over with Volume 2, Issue 2. My term as editor will come to a more
routine end this December. On behalf of the entire editorial staff, I
am proud of our accomplishments. Some aspects of The Hematologist
have changed, while others have remained the same. The Diffusion
articles, as written by our exemplary contributing editors, remain the
firm foundation of this publication. A couple of these editors have
been with The Hematologist from the start, Joe Prchal and Roy Silverstein. The Hematologist
is now published every other month, and has cemented itself as a
mainstay in the fabric of ASH. I feel quite privileged to have been
part of the start of a new tradition.
At the recommendation of the Editor Search Committee of ASH, Roy L. Silverstein, MD, has been named the new editor-in-chief of The Hematologist
and will take over with Volume 6, Issue 1. His term will extend through
2011. Dr. Silverstein is chairman of the Department of Cell Biology and
vice chair for Translational Research in the Lerner Research Institute
of Cleveland Clinic Foundation as well as professor of molecular
medicine at the Cleveland Clinic Lerner College of Medicine of Case
Western Reserve University. Dr. Silverstein holds the Jan Bleeksma
Endowed Chair in Vascular Biology at Cleveland Clinic. His clinical
interests are thrombosis and bleeding disorders. He currently directs
an NHLBI-funded Specialized Center of Clinically Oriented Research
(SCCOR) in thrombosis and is funded by four different grant programs
from NHLBI.
Dr. Silverstein served as a contributing editor for The Hematologist from 2004-2007 and has been "shadowing" me over much of 2008. He also was on the editorial board of Blood from 1997-2002. His other editorial board experience includes an advisory editor position with the Journal of Experimental Medicine from 2004-2008, consulting editor of the Journal of Clinical Investigation from 2003-2010, and member of the Editorial Advisory Board of Current Immunology Reviews.
His other responsibilities within ASH have been numerous, including
serving as chair of the Government Affairs Committee from 2005-2008.
Dr. Silverstein stated that he is "committed to the concept of
data-driven decision making" and believes "that the driving force of
the publication should remain the Diffusion pieces." Given that Dr.
Silverstein has been involved with The Hematologist from the start, I feel confident that I'm leaving the publication in good hands.
back to top
